2017
DOI: 10.3399/bjgp17x692129
|View full text |Cite
|
Sign up to set email alerts
|

Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain

Abstract: Initial medication non-adherence seems to have a short-term impact on productivity losses and costs. The clinical consequences and long-term economic consequences of initial medication non-adherence need to be assessed. Interventions to promote initial medication adherence in primary care may reduce costs and improve health outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
10
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 24 publications
0
10
0
2
Order By: Relevance
“…Moreover, even from a short -term perspective, initial medication nonadherence has a negative impact on productivity due to lower work ability and leads to increased net costs. 11 The Polish healthcare system, like many other European systems, is a health insurance system based on a principle of social solidarity. Health services are provided free of charge to those insured (ie, practically the entire population) by both public and private healthcare providers, and are paid by the only national health payer-the Polish National Health Fund (Narodowy Fundusz Zdrowia).…”
mentioning
confidence: 99%
“…Moreover, even from a short -term perspective, initial medication nonadherence has a negative impact on productivity due to lower work ability and leads to increased net costs. 11 The Polish healthcare system, like many other European systems, is a health insurance system based on a principle of social solidarity. Health services are provided free of charge to those insured (ie, practically the entire population) by both public and private healthcare providers, and are paid by the only national health payer-the Polish National Health Fund (Narodowy Fundusz Zdrowia).…”
mentioning
confidence: 99%
“…The number is assumed to be higher in developing countries, given limited access to healthcare services and paucity of medical providers and finances. Medication nonadherence has been frequently reported to be associated with adverse clinical outcomes [ 2 ], decreased quality of life [ 3 ], as well as higher utilisation of healthcare resources [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Nonadherence worsens health outcomes and increases the risk of mortality and hospitalization (Xu et al, 2017;Kim et al, 2018). Greater use of medical services and productivity losses are also consequences of medication nonadherence, which places a significant cost burden on healthcare systems (Aznar-Lou et al, 2017;Cutler et al, 2018). Nonadherence is higher when more expensive medicines are prescribed and when copayment is applied (Kazerooni et al, 2013;González López-Valcárcel et al, 2017;Aznar-Lou et al, 2018); interventions that reduce the copayment contributions or exempt the patient from payment have effectively proven to reduce nonadherence (Chernew et al, 2008;Maciejewski et al, 2010).…”
Section: Introductionmentioning
confidence: 99%